Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden

202146 citationsJournal Articlegold Open Access

Authors

Rosa Lauppe · Quantify Research (Sweden)

Johan Liseth Hansen · University of Oslo

C. Gerdesköld · Pfizer (Sweden)

Mark H. Rozenbaum · Pfizer (Netherlands)

Anne Mette Strand

Merja Väkeväinen

Johanna Kuusisto · University of Eastern Finland

Einar Gude ·

Abstract

This study provides the first nationwide estimates of ATTR-CM prevalence and risk factors. The results reinforce the severity of the disease and the importance of earlier diagnosis, especially for female patients, in order to allow effective treatment and prevention of disease progression.

Topics & Keywords

Amyloidosis: Diagnosis, Treatment, Outcomes Cellular transport and secretion Parathyroid Disorders and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Open Heart

Volume 8, Issue 2, pp. e001755-e001755

DOI: 10.1136/openhrt-2021-001755

Field-Weighted Citation Impact: 2.43